A recent study by Zhang et al. [44] illustrated that this ERK-mediated phosphorylation of EPLIN is itself regulated by epidermal growth factor (EGF) and revealed how targeting this signalling cascade can be manipulated to reduce epithelial–mesenchymal transition (EMT) and, thus, prostate cancer invasiveness [44]. This evidence concerns the gene EGF and prostate carcinoma.